Author

G. Pelicci

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 2 Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Organism:human· 4 Research Focus:cell type annotation· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell-cell communication· 2 Research Focus:clustering· 2 Assay:imaging· 2 Assay:bulk RNA-seq· 1

Frequent Co-Authors

M. Crestani· 3 shared P. Maiuri· 3 shared P. Monzo· 3 shared C. Maderna· 2 shared C. Richichi· 2 shared D. Osti· 2 shared F. Iannelli· 2 shared M. Giannotta· 2 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiophysics

M. Crestani

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Unraveling Glioblastoma Heterogeneity: Introducing SP2G Method for Identifying Invasive Sub-Populations

M. Crestani, N. Kakogiannos, F. Iannelli, T. Dini, C. Maderna, M. Giannotta, G. Pelicci, P. Maiuri, P. Monzo, N. Gauthier

The paper introduces SP2G, a method to identify invasive sub-populations in glioblastoma cells by analyzing their motility on gridded micropatterns and linking it to molecular markers.

bioRxiv · Jan 10, 2024 · PreprintBiophysics

SP2G: an imaging and analysis pipeline revealing the inter and intra-patient migratory diversity of glioblastoma

M. Crestani, N. Kakogiannos, F. Iannelli, T. Dini, C. Maderna, M. Giannotta, G. Pelicci, P. Maiuri, P. Monzo, N. C. Gauthier

SP2G identifies invasive glioblastoma sub-populations through an in vivo mimicry platform and imaging analysis, revealing intra-patient heterogeneity in cell motility.

bioRxiv · Feb 24, 2023 · PreprintBiophysics

Metformin antiproliferative activity is exclusively mediated by the membrane functional expression of the Chloride Intracellular Channel 1 in glioblastoma stem cells

I. Verduci, F. Cianci, R. Cazzoli, G. Cannavale, M. Veronesi, B. Balboni, M. Ranucci, L. M. G. Palloni, C. Richichi, S. Faletti, D. Osti, G. Ailuno, G. Caviglioli, C. Tacconi, S. GIROTTO, , M. Mazzanti

This study identifies tmCLIC1 as the specific metformin receptor in glioblastoma stem cells, showing that metformin's antiproliferative effect depends on its binding to tmCLIC1 and subsequent inhibition of mitochondrial respiration.

bioRxiv · Dec 31, 2022 · PreprintCancer Biology

Adaptive mechanoproperties characterize glioblastoma fitness for invasion

P. Monzo, M. Crestani, Y. K. Chong, K. Hennig, A. Ghisleni, Q. Li, C. Richichi, P. Maiuri, M. Balland, M. P. Sheetz, G. Pelicci, B. T. Ang, C. Tang, N. C. Gauthier

The paper identifies FMN1 as a driver of glioblastoma invasiveness by linking it to increased cell stiffness, mechanical forces, and stochastic motility.

bioRxiv · Jun 17, 2020Cell Biology

ZBTB18 inhibits SREBP-dependent fatty acid synthesis by counteracting CTBPs and KDM1A/LSD1 activity in glioblastoma

R. Ferrarese, A. Izzo, G. Andrieux, S. Lagies, J. P. Bartmuss, A. P. Masilamani, A. Wasilenko, D. Osti, S. Faletti, R. Schulzki, S. Yuan, E. Kling, V. Ribecco, H. D. Heiland, S. G. Tholen, , M. S. Carro

This study identifies ZBTB18 as a regulator of SREBP gene expression in glioblastoma by modulating CTBP and LSD1 activity, leading to epigenetic repression of fatty acid synthesis.

bioRxiv · Apr 17, 2020 · PreprintCancer Biology